MX2021005963A - Caracterizacion de adn metilado, arn y proteinas en la deteccion de neoplasia pulmonar. - Google Patents
Caracterizacion de adn metilado, arn y proteinas en la deteccion de neoplasia pulmonar.Info
- Publication number
- MX2021005963A MX2021005963A MX2021005963A MX2021005963A MX2021005963A MX 2021005963 A MX2021005963 A MX 2021005963A MX 2021005963 A MX2021005963 A MX 2021005963A MX 2021005963 A MX2021005963 A MX 2021005963A MX 2021005963 A MX2021005963 A MX 2021005963A
- Authority
- MX
- Mexico
- Prior art keywords
- detection
- characterization
- rna
- proteins
- methylated dna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862771965P | 2018-11-27 | 2018-11-27 | |
| PCT/US2019/063401 WO2020112869A1 (en) | 2018-11-27 | 2019-11-26 | Characterizing methylated dna, rna, and proteins in the detection of lung neoplasia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021005963A true MX2021005963A (es) | 2021-08-24 |
Family
ID=70853661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021005963A MX2021005963A (es) | 2018-11-27 | 2019-11-26 | Caracterizacion de adn metilado, arn y proteinas en la deteccion de neoplasia pulmonar. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220136058A1 (https=) |
| EP (1) | EP3886878A4 (https=) |
| JP (2) | JP7512278B2 (https=) |
| KR (1) | KR102945867B1 (https=) |
| CN (1) | CN113423410A (https=) |
| AU (1) | AU2019389008A1 (https=) |
| BR (1) | BR112021009795A2 (https=) |
| CA (1) | CA3119329A1 (https=) |
| MX (1) | MX2021005963A (https=) |
| WO (1) | WO2020112869A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2816122A1 (en) | 2008-02-15 | 2014-12-24 | Mayo Foundation For Medical Education And Research | Detecting neoplasm from a stool sample |
| US8361720B2 (en) | 2010-11-15 | 2013-01-29 | Exact Sciences Corporation | Real time cleavage assay |
| US8916344B2 (en) | 2010-11-15 | 2014-12-23 | Exact Sciences Corporation | Methylation assay |
| ES2859645T3 (es) | 2013-03-14 | 2021-10-04 | Mayo Found Medical Education & Res | Detección de neoplasia |
| EP4234722A3 (en) | 2014-03-31 | 2023-09-20 | Mayo Foundation for Medical Education and Research | Detecting colorectal neoplasm |
| US10184154B2 (en) | 2014-09-26 | 2019-01-22 | Mayo Foundation For Medical Education And Research | Detecting cholangiocarcinoma |
| CN107532124B (zh) | 2015-03-27 | 2022-08-09 | 精密科学公司 | 检测食管疾病 |
| CN108138235B (zh) | 2015-08-31 | 2022-04-15 | 梅约医药教育及研究基金会 | 检测胃肿瘤 |
| AU2016343937B2 (en) | 2015-10-30 | 2023-01-19 | Exact Sciences Corporation | Multiplex amplification detection assay and isolation and detection of DNA from plasma |
| CN116064796A (zh) | 2016-05-05 | 2023-05-05 | 精密科学公司 | 通过分析甲基化dna来检测肺肿瘤 |
| KR102892245B1 (ko) | 2017-01-27 | 2025-11-27 | 이그젝트 싸이언스 디블롭먼트 컴패니, 엘엘씨 | 메틸화된 dna 분석에 의한 결장 신조직형성의 검출 |
| US10975443B2 (en) | 2017-11-30 | 2021-04-13 | Mayo Foundation For Medical Education And Research | Detecting breast cancer |
| US10648025B2 (en) | 2017-12-13 | 2020-05-12 | Exact Sciences Development Company, Llc | Multiplex amplification detection assay II |
| US12584177B2 (en) | 2019-01-24 | 2026-03-24 | Mayo Foundation For Medical Education And Research | Detecting endometrial cancer |
| WO2021041726A1 (en) * | 2019-08-27 | 2021-03-04 | Exact Sciences Development Company, Llc | Characterizing methylated dna, rna, and proteins in subjects suspected of having lung neoplasia |
| WO2021055508A1 (en) | 2019-09-16 | 2021-03-25 | Exact Sciences Development Company, Llc | Structure and temperature-dependent flap endonuclease substrates |
| CA3154354A1 (en) | 2019-10-31 | 2021-05-06 | William R. Taylor | Detecting ovarian cancer |
| US11898199B2 (en) | 2019-11-11 | 2024-02-13 | Universal Diagnostics, S.A. | Detection of colorectal cancer and/or advanced adenomas |
| WO2021228418A1 (en) | 2020-05-15 | 2021-11-18 | Universal Diagnostics, S.L. | Methods and systems for identifying methylation biomarkers |
| WO2022002424A1 (en) | 2020-06-30 | 2022-01-06 | Universal Diagnostics, S.L. | Systems and methods for detection of multiple cancer types |
| EP3945135A1 (en) * | 2020-07-27 | 2022-02-02 | Les Laboratoires Servier | Biomarkers for diagnosing and monitoring lung cancer |
| AU2022213409A1 (en) * | 2021-01-29 | 2023-08-17 | Exact Sciences Corporation | Detecting the presence or absence of multiple types of cancer |
| CN115505640B (zh) * | 2021-06-22 | 2026-04-07 | 江苏鹍远生物科技股份有限公司 | 检测肺癌的dna甲基化标志物及应用 |
| CN115725734B (zh) * | 2022-08-10 | 2023-10-13 | 人和未来生物科技（长沙）有限公司 | Znf781基因在制备宫颈癌诊断试剂中的应用 |
| US12606872B2 (en) | 2022-11-16 | 2026-04-21 | Universal Diagnostics, S.A. | Methods for stratification and early detection of advanced adenoma and/or colorectal cancer using DNA methylation markers |
| CN117683877A (zh) * | 2023-12-19 | 2024-03-12 | 上海交通大学医学院 | 一种诊断或治疗免疫系统疾病的生物标志物或靶点 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070264659A1 (en) * | 2006-05-11 | 2007-11-15 | Sungwhan An | Lung cancer biomarker discovery |
| JPWO2010064702A1 (ja) * | 2008-12-05 | 2012-05-10 | 国立大学法人 東京大学 | 癌の予後を予測するためのバイオマーカー |
| WO2010074924A1 (en) * | 2008-12-23 | 2010-07-01 | University Of Utah Research Foundation | Identification and regulation of a novel dna demethylase system |
| JP2014531213A (ja) * | 2011-09-30 | 2014-11-27 | ジェネンテック， インコーポレイテッド | 上皮又は間葉の表現型の診断用メチル化マーカー、及び腫瘍又は腫瘍細胞におけるｅｇｆｒキナーゼ阻害薬に対する応答 |
| WO2013070950A1 (en) * | 2011-11-08 | 2013-05-16 | University Of Southern California | Identification of a dna methylation marker for blood-based detection of ovarian cancer |
| US9546403B1 (en) * | 2011-12-14 | 2017-01-17 | University Of Utah Research Foundation | Substrate for methylated DNA testing |
| ES2879964T3 (es) * | 2014-12-12 | 2021-11-23 | Exact Sciences Dev Co Llc | Composiciones y métodos para realizar ensayos de detección de metilación |
| JP6877704B2 (ja) * | 2015-11-16 | 2021-05-26 | 公立大学法人名古屋市立大学 | 膵臓癌の検出のための方法及びキット |
| CN116064796A (zh) * | 2016-05-05 | 2023-05-05 | 精密科学公司 | 通过分析甲基化dna来检测肺肿瘤 |
| AU2017281099A1 (en) * | 2016-06-21 | 2019-01-03 | The Wistar Institute Of Anatomy And Biology | Compositions and methods for diagnosing lung cancers using gene expression profiles |
| EP3488004B1 (en) * | 2016-07-19 | 2021-10-06 | Exact Sciences Development Company, LLC | Methylated control dna |
-
2019
- 2019-11-26 BR BR112021009795-3A patent/BR112021009795A2/pt unknown
- 2019-11-26 EP EP19890483.1A patent/EP3886878A4/en active Pending
- 2019-11-26 WO PCT/US2019/063401 patent/WO2020112869A1/en not_active Ceased
- 2019-11-26 KR KR1020217019972A patent/KR102945867B1/ko active Active
- 2019-11-26 JP JP2021530259A patent/JP7512278B2/ja active Active
- 2019-11-26 CN CN201980077665.3A patent/CN113423410A/zh active Pending
- 2019-11-26 US US17/297,356 patent/US20220136058A1/en active Pending
- 2019-11-26 MX MX2021005963A patent/MX2021005963A/es unknown
- 2019-11-26 AU AU2019389008A patent/AU2019389008A1/en active Pending
- 2019-11-26 CA CA3119329A patent/CA3119329A1/en active Pending
-
2024
- 2024-06-26 JP JP2024103130A patent/JP2024123233A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7512278B2 (ja) | 2024-07-08 |
| CN113423410A (zh) | 2021-09-21 |
| CA3119329A1 (en) | 2020-06-04 |
| KR102945867B1 (ko) | 2026-03-31 |
| US20220136058A1 (en) | 2022-05-05 |
| KR20210099044A (ko) | 2021-08-11 |
| EP3886878A4 (en) | 2022-11-02 |
| EP3886878A1 (en) | 2021-10-06 |
| WO2020112869A1 (en) | 2020-06-04 |
| BR112021009795A2 (pt) | 2021-08-17 |
| JP2022513658A (ja) | 2022-02-09 |
| AU2019389008A1 (en) | 2021-06-03 |
| JP2024123233A (ja) | 2024-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021005963A (es) | Caracterizacion de adn metilado, arn y proteinas en la deteccion de neoplasia pulmonar. | |
| AU2020336115A8 (en) | Characterizing methylated DNA, RNA, and proteins in subjects suspected of having lung neoplasia | |
| CY1124106T1 (el) | Συνθεσεις μεταφορεα-αντισωματος και μεθοδοι παρασκευης και χρησης αυτων | |
| CY1123823T1 (el) | Βελτιωμενες συνθεσεις τ κυτταρων | |
| MX2023014569A (es) | Anticuerpos anti-sirpa. | |
| MX2015011514A (es) | Compuestos de heteroarilo y sus usos. | |
| CR20150524A (es) | Compuestos de heteroarilo y sus usos | |
| JOP20200342A1 (ar) | مشتقات بيرازين مدمجة كمثبطات a2a/a2b | |
| BR112016005957A2 (pt) | detecção de alvo multiaptâmero | |
| ECSP15043696A (es) | Compuestos de heteroarilo y sus usos | |
| MX385213B (es) | Ligadores de nucleótidos modificados. | |
| EA201692425A1 (ru) | Модифицированные биополимеры и способы их получения и использования | |
| CO2017005842A2 (es) | Anticuerpos heterodiméricos que se unen a cd3 y cd38 | |
| MX384024B (es) | Peptidos macrociclicos utiles como inmunomoduladores. | |
| UY36862A (es) | Conjugados anticuerpo anti-dll3-fármaco y métodos de uso | |
| GB2539350A (en) | Amyloid targeting agents and methods of using the same | |
| EA201690529A1 (ru) | Способы модификации клетки-хозяина | |
| MX380520B (es) | Anticuerpos receptores de antitransferina y métodos de uso. | |
| UY35385A (es) | ?métodos y composiciones para el control de malezas?. | |
| EA201291194A1 (ru) | Индолы | |
| UY34342A (es) | ?derivados de pirrolopirimidina y purina?. | |
| AR093446A1 (es) | Anticuerpos de antihemaglutinina y metodos de uso | |
| GB2537077A (en) | Methods for sequencing nucleic acids | |
| BR112018010279A2 (pt) | novos anticorpos anti-emr2 e métodos de uso | |
| CL2017000506A1 (es) | Nuevos anticuerpos anti-mfi2 y metodos de uso |